GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tsubota Laboratory Inc (TSE:4890) » Definitions » Notes Receivable

Tsubota Laboratory (TSE:4890) Notes Receivable : 円0.0 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tsubota Laboratory Notes Receivable?

Tsubota Laboratory's Notes Receivable for the quarter that ended in Dec. 2023 was 円0.0 Mil.


Tsubota Laboratory Notes Receivable Historical Data

The historical data trend for Tsubota Laboratory's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsubota Laboratory Notes Receivable Chart

Tsubota Laboratory Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Notes Receivable
- - - - -

Tsubota Laboratory Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tsubota Laboratory Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Tsubota Laboratory Notes Receivable Related Terms

Thank you for viewing the detailed overview of Tsubota Laboratory's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsubota Laboratory (TSE:4890) Business Description

Traded in Other Exchanges
N/A
Address
34 Shinanomachi, 304 Toshin Shinanomachi-ekimae Building, Shinjuku-ku, Tokyo, JPN, 160-0016
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.

Tsubota Laboratory (TSE:4890) Headlines

No Headlines